Dr Maya Dannawi is currently a Postdoctoral researcher in the Department of Pharmacology, working on a Wellcome Trust Discovery Award project, ENDASCOP. As a neuroscientist specialising in pain, Dr Dannawi's current research centres on the neural mechanisms of chronic pain, with a particular focus on osteoarthritic (OA) pain.
The project aims to elucidate the role of distinct knee-innervating afferent neuronal subpopulations in the development and maintenance of OA pain, as well as to map the spinal circuits these afferents innervate under both normal and pathological conditions.
Dr Dannawi obtained her PhD in 2024, supported by an FNRS scholarship at Université Libre de Bruxelles and an FWA scholarship during her time as a visiting PhD student at the University of Cambridge. Her doctoral research focused on PRDM12, a transcriptional regulator associated with congenital insensitivity to pain.
She explored PRDM12’s role in the development and signalling of nociceptors (pain-sensing neurons), with the goal of advancing our understanding of pain pathways and offering new opportunities for therapeutic interventions.
Additionally, she holds an MSc in Physiology from the American University of Beirut, where her thesis explored the mechanistic pathways of intermittent fasting and its impact on prediabetes-induced neuropathy, proposing a novel mechanism involved in its pathogenesis and complications.